MELINDA KAY MARZOLF

Allopathic & Osteopathic Physicians|Family Medicine MONTROSE, CO NPI 1013177526

General Payments — all program years on this page

$1,179.58

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 66
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $309.66 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $309.6614

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $150.026
Acerta Pharma LLC $59.813
Astellas Pharma US Inc $45.092
AIMMUNE THERAPEUTICS, INC. $20.741
Novo Nordisk AS $19.611
Lilly USA, LLC $14.391

By program year

Program yearAmountRecords
2021 $165.6410
2022 $356.4723
2023 $347.8119
2024 $309.6614

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096598440 Novo Nordisk Inc $19.61 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104312682 AstraZeneca Pharmaceuticals LP $15.19 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104348438 AstraZeneca Pharmaceuticals LP $24.24 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104978173 ABBVIE INC. $24.43 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104978175 ABBVIE INC. $20.21 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104978177 ABBVIE INC. $16.02 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104978179 ABBVIE INC. $24.18 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104978181 ABBVIE INC. $46.14 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104978183 ABBVIE INC. $19.04 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105781988 AstraZeneca Pharmaceuticals LP $20.38 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135188403 Lilly USA, LLC $14.39 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139371923 Astellas Pharma US Inc $23.20 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139433950 Astellas Pharma US Inc $21.89 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147021411 AIMMUNE THERAPEUTICS, INC. $20.74 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.